Emergent Biosolutions reported $-72000000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amarin AMRN:US -37619000 9.31M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Chimerix CMRX:US -23447000 1.32M
Emergent Biosolutions EBS:US $ -72000000 78.4M
Exact Sciences EXAS:US $ -152993000 23.99M
Glaxosmithkline GSK:US 1.82B 600M
Immunogen IMGN:US $ -61053000 38.2M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
Ironwood Pharmaceuticals IRWD:US $ 55.65M 2.19M
JAZZ PHA JAZZ:US 126.35M 38.8M
Lexicon Pharmaceuticals LXRX:US -24007000 627K
Lonza Group LONN:SW 667M 116M
Merk MRK:US $ 5711M 652M
Moderna Inc MRNA:US 2.45B 1.78B
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Opko Health OPK:US $ -26104000 46.32M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Pfizer PFE:US $ 12099M 2104M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Seattle Genetics SGEN:US $ -133111000 61K
Teva Pharmaceutical Industries TEVA:US 734M 55M
United Therapeutics UTHR:US $ 201.8M 86.2M
Xoma XOMA:US $ -4767000 2.7M